Status: current, Primitive. Date: 31-Jul 2015. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3082832019 | Daclatasvir (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3082833012 | Daclatasvir | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daclatasvir | Is a | Hepatitis C virus protein NS5A inhibitor | true | Inferred relationship | Some | ||
| Daclatasvir | Has disposition | Hepatitis C virus protein NS5A inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Daclatasvir only product | Has active ingredient | True | Daclatasvir | Inferred relationship | Some | 1 |
| Daclatasvir only product in oral dose form | Has active ingredient | True | Daclatasvir | Inferred relationship | Some | 1 |
| Daclatasvir dihydrochloride | Is modification of | True | Daclatasvir | Inferred relationship | Some | |
| Daclatasvir (as daclatasvir dihydrochloride) 60 mg oral tablet | Has BoSS | True | Daclatasvir | Inferred relationship | Some | 1 |
| Daclatasvir (as daclatasvir dihydrochloride) 30 mg oral tablet | Has BoSS | True | Daclatasvir | Inferred relationship | Some | 1 |
| Daclatasvir (as daclatasvir dihydrochloride) 90 mg oral tablet | Has BoSS | True | Daclatasvir | Inferred relationship | Some | 1 |
| Daclatasvir-containing product | Has active ingredient | True | Daclatasvir | Inferred relationship | Some | 1 |
| Daclatasvir-containing product in oral dose form | Has active ingredient | True | Daclatasvir | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR